The MIST Therapy system for the promotion of wound healing (MTG5)
Evidence-based recommendations on the MIST Therapy system for the promotion of wound healing.
Evidence-based recommendations on the MIST Therapy system for the promotion of wound healing.
Evidence-based recommendations on Ambulight PDT for the treatment of non-melanoma skin cancer.
In November 2016, NICE reviewed this guidance and recommended that it should be withdrawn. The guidance was published in June 2011 and recommended that further research was carried out on the technology. There was insufficient evidence on its use in clinical practice to recommend adoption. On reviewing the guidance in 2016, NICE determined that: The comparator in the original guidance, standard serial troponin testing, was changed in 2014 to high sensitivity troponin testing which expert advice indicated is now widespread in the NHS The clinical pathway in the original evaluation has significantly changed and the original scope is no longer valid. These changes mean that the current guidance is no longer valid and NICE would not be able to update it. The guidance has therefore been withdrawn. For a copy of the review decision please contact nice@nice.org.uk.
This medical technologies guidance has been replaced by the recommendation on cardiac output monitoring in the NICE guideline on perioperative care in adults.
This medical technologies guidance has been replaced by the recommendations in the NICE guideline on acute coronary syndromes.
Discontinued [GID-MT516]
Status ...
Discontinued [GID-MT117]
Discontinued [GID-MT510]
Status ...
Status ...
Status ...
In development [GID-MT591] Expected publication date: TBC
Discontinued [GID-HST10038]
Discontinued [GID-MT267]
In development [GID-HST10032] Expected publication date: TBC
Discontinued [GID-HST10004]
Discontinued [GID-MT517]
Discontinued [GID-HST10007]
In development [GID-MT538] Expected publication date: TBC
Discontinued [GID-MT544]
Awaiting development [GID-HST10022] Expected publication date: TBC
In development [GID-MT563] Expected publication date: TBC
In development [GID-MT526] Expected publication date: TBC
In development [GID-MT557] Expected publication date: TBC
In development [GID-MT567] Expected publication date: TBC
Discontinued [GID-MT130]
Discontinued [GID-MT81]
Discontinued [GID-MT163]
Awaiting development [GID-MT599] Expected publication date: TBC
In development [GID-HST10033] Expected publication date: TBC
Status ...
Discontinued [GID-MT536]
In development [GID-HST10037] Expected publication date: TBC
Awaiting development [GID-MT602] Expected publication date: TBC
Awaiting development [GID-MT603] Expected publication date: TBC
Discontinued [GID-HST10019]
In development [GID-MT593] Expected publication date: TBC
In development [GID-MT594] Expected publication date: TBC
In development [GID-HST10020] Expected publication date: TBC
Status ...
Awaiting development [GID-MT609] Expected publication date: TBC
Awaiting development [GID-MT607] Expected publication date: TBC
Awaiting development [GID-MT608] Expected publication date: TBC
In development [GID-HST10059] Expected publication date: 18 December 2024
Awaiting development [GID-MT610] Expected publication date: TBC
In development [GID-MT605] Expected publication date: 19 December 2024
In development [GID-HST10055] Expected publication date: 11 September 2024
In development [GID-HST10060] Expected publication date: TBC
In development [GID-HST10054] Expected publication date: TBC